Cloning: Do we even need eggs?

Nature

Volumn 439, Issue 7077, 2006, Pages 655-657

  Brown, Phyllida ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN; IMMUNOLOGIC AGENT; STEROID;

BIOLOGY;

AUTOIMMUNE DISEASE; CANCER RISK; CELL CLONING; CELL INTERACTION; DENDRITIC CELL; EXPERIMENTAL MOUSE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY FAILURE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHORT SURVEY; SIDE EFFECT; SURVIVAL TIME; T CELL DEPLETION; TISSUE GRAFT; TRANSPLANTATION TOLERANCE; UNITED KINGDOM;

EID: 32544437045     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/439655a     Document Type: Short Survey

References (7)

1. Watson, C. J. et al. Am. J. Transplant. 5, 1347-1353 (2005).
2. Billingham, R. et al. Nature 172, 603-606 (1953).
3. Buhler, L. H. et al. Transplantation 74, 1405-1409 (2002).
4. Steinman, R. M. et al. Annu. Rev. Immunol. 21, 685 (2003).
5. Fairchild, P. J. et al. Curr. Biol. 10, 1515-1518 (2000).
6. Fairchild, P. J. et al. Trends Immunol. 25, 465-470 (2004).
7. Fairchild, P. J. et al. Intl. Immunopharmacol. 5, 13-21 (2005).